Cell Culture – Products

Product News
Quick Differentiation Kits for iPSC Derived Neurons
Amsbio introduces iPSC kits for rapid, scalable and reproducible neural cell differentiation, enhancing flexibility for disease modeling and drug screening.

Product News
Fujifilm Rebrands Life Sciences Companies To Strengthen Position As Strategic Partners for Life
FUJIFILM Life Sciences Group rebrands FUJIFILM Biosciences and FUJIFILM Biotechnologies to streamline its global strategy.

Product
Advertisement
Faster & Purer US-Based Recombinant Production
Sino Biological, with 15+ years of experience, has developed a proprietary mammalian transient expression platform using HEK293 and CHO cells.

Product News
Waters Introduces BioResolve Protein a Affinity Columns To Accelerate Antibody Titer Measurement
Waters Corporation launches BioResolve Protein A Affinity Columns to accelerate antibody development with precise titer measurements and faster method optimization.

Product
Advertisement
Cyto-Mine® Chroma: Unmatched Single-Cell Analysis with Multiplexing Power
Cyto-Mine® Chroma is a multiplexing-capable, fully-automated single cell analysis platform that can encapsulate, analyze, sort, and dispense viable single cells.

Product News
Bionova Scientific Licenses ATUM’s Proprietary Transposon-Based Gene Delivery Technology
Bionova licenses ATUM’s Leap-In tech to speed up cell line development and streamline biologics manufacturing.

Product News
Thermo Fisher Scientific Introduces the 1500 Series Class II, Type A2 Biological Safety Cabinet
Thermo Fisher’s new 1500 Series BSC boosts lab safety, ergonomic comfort and workflow with real-time airflow tech.

Product News
Thermo Fisher Scientific Leverages Integrated Solutions To Accelerate the Development of Biologic Therapeutics
Thermo Fisher’s enhanced CHO K-1 cell line reduces IND filing time and increases protein expression for biologics.

Product News
Metrion Biosciences Launches NaV1.9 High-Throughput Screening Assay To Strengthen Screening Portfolio
Metrion Biosciences launches a validated NaV1.9 screening assay to advance non-opioid pain therapeutic development.

Product News
GlymaxX®-Enhanced Antibody Now Commercially Available for Innovative Cancer Therapy
ProBioGen’s GlymaxX technology supports the FDA-approved Ziihera® antibody for HER2-positive biliary tract cancer, advancing targeted therapies.
Advertisement